Literature DB >> 14707050

Marginal zone, but not follicular B cells, are potent activators of naive CD4 T cells.

Kalaya Attanavanich1, John F Kearney.   

Abstract

The early involvement of marginal zone (MZ) B lymphocytes in T-independent immune responses is well established. In this study we compared the abilities of MZ and follicular (FO) B cells to collaborate with T cells. After immunization with soluble hen egg lysozyme, both MZ and FO B cells captured Ag and migrated to T cell areas in the response to hen egg lysozyme. MZ B cells were far superior to FO B cells in inducing CD4+ T cell expansion both in vitro and in vivo. MZ, but not FO, B cells, after interaction with T cells, differentiated into plasma cells, and in addition they stimulated Ag-specific CD4+ T cells to produce high levels of Th1-like cytokines upon primary stimulation in vitro. These results indicate that MZ B cells rapidly and effectively capture soluble Ag and activate CD4+ T cells to become effector T cells. The enhanced capacity of MZ B cells to prime T cells in this study appeared to be intrinsic to MZ B cells, as both MZ and FO B cell populations express an identical Ag receptor.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14707050     DOI: 10.4049/jimmunol.172.2.803

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  93 in total

1.  Identification and characterization of a lupus suppressor 129 locus on chromosome 3.

Authors:  Francesco Carlucci; Liliane Fossati-Jimack; Ingrid E Dumitriu; Yasin Heidari; Mark J Walport; Marta Szajna; Paramita Baruah; Oliver A Garden; H Terence Cook; Marina Botto
Journal:  J Immunol       Date:  2010-04-30       Impact factor: 5.422

2.  Stat3 inhibition augments the immunogenicity of B-cell lymphoma cells, leading to effective antitumor immunity.

Authors:  Fengdong Cheng; Hongwei Wang; Pedro Horna; Zi Wang; Bijal Shah; Eva Sahakian; Karrune V Woan; Alejandro Villagra; Javier Pinilla-Ibarz; Said Sebti; Mitchell Smith; Jianguo Tao; Eduardo M Sotomayor
Journal:  Cancer Res       Date:  2012-06-22       Impact factor: 12.701

Review 3.  B Cells, Antibodies, and More.

Authors:  William Hoffman; Fadi G Lakkis; Geetha Chalasani
Journal:  Clin J Am Soc Nephrol       Date:  2015-12-23       Impact factor: 8.237

Review 4.  A biological context for the self-nonself discrimination and the regulation of effector class by the immune system.

Authors:  Melvin Cohn
Journal:  Immunol Res       Date:  2005       Impact factor: 2.829

Review 5.  The common sense of the self-nonself discrimination.

Authors:  Melvin Cohn
Journal:  Springer Semin Immunopathol       Date:  2005-02-15

6.  In vivo disruption of tolerogenic cross-presentation mechanisms uncovers an effective T-cell activation by B-cell lymphomas leading to antitumor immunity.

Authors:  Pedro Horna; Alex Cuenca; Fengdong Cheng; Jason Brayer; Hong-Wei Wang; Ivan Borrello; Hyam Levitsky; Eduardo M Sotomayor
Journal:  Blood       Date:  2005-12-08       Impact factor: 22.113

7.  Cutting edge: Primary and secondary effects of CD19 deficiency on cells of the marginal zone.

Authors:  Yuying You; Hong Zhao; Yue Wang; Robert H Carter
Journal:  J Immunol       Date:  2009-06-15       Impact factor: 5.422

8.  A novel ICOS-independent, but CD28- and SAP-dependent, pathway of T cell-dependent, polysaccharide-specific humoral immunity in response to intact Streptococcus pneumoniae versus pneumococcal conjugate vaccine.

Authors:  Quanyi Chen; Jennifer L Cannons; James C Paton; Hisaya Akiba; Pamela L Schwartzberg; Clifford M Snapper
Journal:  J Immunol       Date:  2008-12-15       Impact factor: 5.422

9.  Marginal zone B-cell depletion impairs murine host defense against Borrelia burgdorferi infection.

Authors:  Alexia A Belperron; Catherine M Dailey; Carmen J Booth; Linda K Bockenstedt
Journal:  Infect Immun       Date:  2007-04-30       Impact factor: 3.441

10.  Peripheral CD4(+) T-cell tolerance is induced in vivo by rare antigen-bearing B cells in follicular, marginal zone, and B-1 subsets.

Authors:  Susan E Murray; Katelynne Gardner Toren; David C Parker
Journal:  Eur J Immunol       Date:  2013-05-08       Impact factor: 5.532

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.